Emerging role of NLRP3 inflammasome as a therapeutic target in cardiovascular and infectious diseases
-
Chair(s):
Na Li,
Associate Professor, Department of Medicine, Baylor College of Medicine, Houston, TX, The United States of America -
Session description:
Targeting the NLRP3 inflammasome for the treatment of inflammatory diseases
Dr Rebecca Coll
Lecturer in Immunobiology, Queen’s University Belfast, Belfast, United KingdomCaMKII signaling and NLRP3 inflammasome activation in cardiomyocyte mediated inflammation
Professor Joan Heller Brown
Professor and Chair of the Department of Pharmacology, UC San Diego, School of Medicine, United States of AmericaOral communication speaker - to be confirmed in 2023.
Pathological role of NLRP3 inflammasome in the development of atrial fibrillation
Dr Marcel Tekook
Department of Pharmacology, University of Duisburg – Essen Germany, Essen, GermanyInflammasome activation and COVID-19 patients
Stefano Toldo Associate Professor of Medicine, Department of Medicine, Division of Cardiovascular Medicine, University of Virginia, School of Medicine, Molecular Research Building 5 (MR5), Charlottesville, VA, America
Speakers
-
Dr Marcel TekookDepartment of Pharmacology, University of Duisburg – Essen Germany, Essen, Germany
-
Dr Rebecca CollLecturer in Immunobiology, Queen’s University Belfast, Belfast, United Kingdom
-
Professor Joan Heller BrownDistinguished Professor and Chair of the Department of Pharmacology at UC San Diego School of Medicine -
Stefano ToldoStefano Toldo Associate Professor of Medicine, Department of Medicine, Division of Cardiovascular Medicine, University of Virginia, School of Medicine, Molecular Research Building 5 (MR5), Charlottesville, VA, America